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Abstract
Background: The objective of this study was to test the hypothesis that CD8
+ T cells directly mediate motor disability and
axon injury in the demyelinated central nervous system. We have previously observed that genetic deletion of the CD8
+ T
cell effector molecule perforin leads to preservation of motor function and preservation of spinal axons in chronically
demyelinated mice.
Methodology/Principal Findings: To determine if CD8
+ T cells are necessary and sufficient to directly injure demyelinated
axons, we adoptively transferred purified perforin-competent CD8
+ spinal cord-infiltrating T cells into profoundly
demyelinated but functionally preserved perforin-deficient host mice. Transfer of CD8
+ spinal cord-infiltrating T cells rapidly
and irreversibly impaired motor function, disrupted spinal cord motor conduction, and reduced the number of medium-
and large-caliber spinal axons. Likewise, immunodepletion of CD8
+ T cells from chronically demyelinated wildtype mice
preserved motor function and limited axon loss without altering other disease parameters.
Conclusions/Significance: In multiple sclerosis patients, CD8
+ T cells outnumber CD4
+ T cells in active lesions and the
number of CD8
+ T cells correlates with the extent of ongoing axon injury and functional disability. Our findings suggest that
CD8
+ T cells may directly injure demyelinated axons and are therefore a viable therapeutic target to protect axons and
motor function in patients with multiple sclerosis.
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Introduction
The identification of cellular and molecular mediators of axon
injury during chronic demyelination is critical to understanding
and preventing or repairing the loss of function associated with
multiple sclerosis (MS) and other demyelinating diseases of the
central nervous system. At present, the MS field has defined the
following possible mechanisms for axon injury [1]: 1) demyelin-
ation is the necessary and sufficient inciting pathology in MS, with
axons lost as a direct consequence of failed glial support; 2)
demyelination is necessary but not sufficient for axon injury – the
loss of myelin exposes axons to a cytotoxic mileu; 3) demyelination
is necessary but not sufficient for axon injury – the loss of myelin
exposes axons to axopathic immune effectors such as T cells; 4)
neurons and axons are the primary locus for the initiation of MS
pathology, and demyelination follows the injury of axons. These
mechanisms are not mutually exclusive and each is likely to play
an overlapping role in some patients, in some lesions, and at some
stage of disease evolution. Here we focus on the hypothesis that the
loss of myelin is a necessary predisposing factor for axon injury in
MS, but demyelination itself is insufficient to cause axon loss.
Rather, loss of myelin renders the axolemma accessible to CNS
infiltrating immune effectors such as CD8
+ T cells [2–5].
CD8
+ T cells are the most frequent T cell subset observed in
MS lesions, outnumbering CD4
+ T cells by up to 10-fold at sites of
active inflammation [6,7]. The number of CD8
+ T cells found
within acute lesions correlates very well with the extent of ongoing
axon injury exhibited by MS patients [8]. Unlike CD4
+ T cells in
MS lesions, CD8
+ T cells exhibit clonal expansion, suggesting the
recruitment and local proliferation of a distinct, epitope-specific
repertoire in the brain [6,9–11]. Importantly, MHC class I is
upregulated on axons within active MS lesions [12]. Finally, while
anti-CD4 monoclonal antibody treatment failed to alter disease
course in MS patients [13], treatment with alemtuzumab [14], a
monoclonal antibody that depletes both CD8
+ and CD4
+ T cells,
or treatment with natalizumab [15,16], which prevents both CD8
+
and CD4
+ T cell trafficking into the CNS, resulted in a reduction
in relapse rate.
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+ T cells include
cytokine-mediated toxicity, FasL induction of target cell apoptosis,
and target cell killing mediated by perforin and granzyme [17].
Recent evidence suggests that elevation of granzyme levels in the
CSF may correlate with relapse in MS patients [18], and a
considerable literature indicates that CD8
+ T cells mediate at least
some aspects of axon injury in some animal models of MS via a
perforin-dependent pathway [5]. Based on our previous observa-
tions that demyelinated axons and motor function are protected by
the genetic deletion of perforin in the Theiler’s murine
encephalomyelitis virus (TMEV) model of MS [19–22], we have
attempted to further define the role of CD8
+ T cells in the injury of
demyelinated axons. Using the adoptive transfer of a population of
spinal cord infiltrating, acute effector CD8
+ T cells that we have
recently characterized [23], we now report that CD8
+ T cells are
necessary and sufficient to injure demyelinated axons in vivo in a
perforin- and MHC class I-dependent manner.
Results
Axons and motor function are preserved in demyelinated
perforin-deficient mice
Perforin-competent and perforin-deficient mice on an MHC H-
2
q background (B10Q) were infected with 2610
5 PFU TMEV by
intracranial injection at 4–6 weeks of age to induce demyelinating
disease. At 90 days postinfection (dpi), we found that demyelinated
lesion load (Figure 1A) and lesion distribution (Figure 1B–C) were
the same irrespective of perforin expression (P=0.645 by t-test;
Table S1 contains detailed statistical analysis for all measure-
ments). Likewise, viral load in the spinal cord at 90 dpi did not
differ between perforin-competent (5.4560.37 log10 viral copies;
all data are presented as mean695% CI) and perforin-deficient
mice (5.2660.49 log10 copies; P=0.505 by Mann-Whitney rank
sum test). We also found that the number of CD4
+ and CD8
+ T
cells present in a purified population of spinal cord-infiltrating
leukocytes (SCILs) [23] collected at 90 dpi did not differ based on
perforin expression (Figure 1D–F). SCILs from perforin-compe-
tent mice at 90 dpi contained 14926122 CD45
hiCD8
+ cells and
339633 CD45
hiCD4
+ cells, while SCILs from perforin-deficient
mice at 90 dpi contained 14956183 CD45
hiCD8
+ cells (P=0.976
by t-test) and 369680 CD45
hiCD4
+ cells (P=0.523 by t-test)
(Figure S1).
However, despite identical disease progression [19], motor
function in perforin-deficient mice at 90 dpi was remarkably
preserved relative to perforin-competent mice at the same time
point. In fact, demyelinated perforin-deficient mice were indistin-
guishable from uninfected, normally myelinated age-matched
controls by rotarod (P=0.104) (Figure 1G), hanging wire test
(P=0.942) (Figure 1H), and footprint analysis (P=0.948)
(Figure 1I), whereas demyelinated perforin-competent mice under
identical conditions were severely and significantly impaired
(P,0.001 vs perforin-competent and vs uninfected for all
measurements) (Figure 1G–I). Preservation of function in demye-
linated perforin-deficient mice, as compared to demyelinated
perforin-competent mice, was apparent by stride length and
footstep positioning (Figure 1J-L), by open-field video analysis
(Movie S1), by runway video analysis (Movie S2), and by direct
observation of posture (Figure S2).
Loss of function in perforin-competent mice and preservation in
perforin-deficient mice was mirrored in the number of intact axons
present in the thoracic spinal cord at 90 dpi [19–21]. We counted
the absolute number of small- (1–4 mm
2), medium (4–10 mm
2),
and large- (.10 mm
2) caliber axons in plastic-embedded ultrathin
sections of thoracic spinal cord stained with 4% para-phenylene-
diamine [19]. There was no significant difference in the number of
medium- or large-caliber spinal axons between uninfected control
mice and perforin-deficient mice at 90 dpi (P=0.994 for medium
axons; P=0.762 for large axons) (Figure 1M–O). In contrast, in
perforin-competent mice at 90 dpi the number of medium-caliber
axons was reduced to 68% of perforin-deficient levels (P,0.001)
and the number of large-caliber axons was reduced to 53% of
perforin-deficient levels (P,0.001) (Figure 1M–O). At the same
time, small-caliber axons were reduced to 73% of uninfected levels
in perforin-competent mice (P,0.001) and to 87% of uninfected
levels in perforin-deficient mice (P=0.033). However, despite the
reduction of small axons in perforin-deficient mice, there was still
relative preservation as compared to perforin-competent mice
(P=0.031). Thus, we conclude that the absence of perforin in
B10.Q mice protects motor function and spinal axons at 90 dpi
despite demyelinated lesion loads, viral loads, and a SCILs
population that are indistinguishable from perforin-competent
mice at the same time point.
MHC class I is expressed on axons in demyelinated
lesions
Our observations in perforin-deficient B10.Q mice suggested a
primary role for CD8
+ T cells in axon injury and loss of motor
function. A critical component of any model involving CD8
+ T
cells is expression of cognate MHC class I molecules on the target
structure. Histological and immunohistochemical analyses re-
vealed MHC class I expression on longitudinally transverse
structures within demyelinated lesions of the spinal cord at
90 dpi (Figure 2). Demyelinated lesions identified by H&E
(Figure 2A, 2I), Luxol fast blue (Figure 2B, 2J), and Bielschowsky
(Figure 2C, 2K) staining were found to contain MHC class I-
(Figure 2D, 2L) and MHC class II-positive (Figure 2E, 2M)
structures. The MHC class I staining was suggestive of fibers while
the MHC class II staining exhibited a predominantly cellular
profile. Within the same lesions and in proximity to MHC class I-
and II-positive structures, we observed CD8- (Figure 2F, 2N),
Figure 1. Function and axons are protected in the absence of perforin. Absence of perforin confers protection of motor function and
preservation of spinal axons in the demyelinated spinal cord at 90 dpi. All data are presented as mean 695% C.I. Statistical significance defined as
*P,0.05, **P,0.01, ***P,0.001. Significance determined by one-way ANOVA with SNK pairwise posthoc analysis, except demyelination, which was
analyzed by t-test. All measurements made at 90 dpi. Uninf = uninfected control mice; PFP+/+ = perforin-competent mice; PFP2/2 = perforin-
deficient mice. (A–C) The percent (A) and distribution (B–C) of spinal cord white matter that was demyelinated did not differ at 90 dpi between
perforin-competent (B) or perforin-deficient (C) mice. Arrows indicate demyelinated lesions. Arrowheads indicate normal-appearing white matter. (D–
F) Very few CD45
hiCD4
+ or CD45
hiCD8
+ leukocytes were present in the spinal cord of uninfected mice (D). No difference in the number of CD45
hiCD4
+
or CD45
hiCD8
+ cells in the spinal cord infiltrating leukocytes (SCILs) was observed between perforin-competent (E) and perforin-deficient (F) mice at
90 dpi. (G–I) Motor function as assessed by rotarod (G), hanging wire test (H), and footprint analysis (I) was significantly impaired in perforin-
competent mice at 90 dpi but was preserved in perforin-deficient mice at the same time point. (J–L) Representative examples of stride. Scale bar
represent 10 mm. (M–O) As with function, small- (M), medium- (N), and large- (O) caliber axons were preserved in perforin-deficient mice as
compared to perforin-competent mice at 90 dpi. Medium- and large-caliber axons were preserved to uninfected control levels in perforin-deficient
mice.
doi:10.1371/journal.pone.0012478.g001
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Higher magnification analysis of a demyelinated lesion (Figure 2Q)
revealed many MHC class I-positive fiber-like structures
(Figure 2R) spatially associated with accumulations of the axon
injury marker APP (Figure 2S) and in proximity to CD8-positive
immune cells (Figure 2T). Finally, double-labeling immunofluo-
rescence analysis of demyelinated lesions in the spinal cord
provided evidence of MHC class I-positive (Figure 3A, 3C)
neurofilament-containing fibers (Figure 3B) exhibiting structural
characteristics consistent with injured axons. We conclude that
demyelinated axons in the B10.Q spinal cord at 90 dpi have the
requisite MHC class I expression necessary to interact with CD8
+
T cells.
Adoptive transfer of perforin-competent SCILs ablates
host axons and function
To directly test our hypothesis regarding the role of CD8
+ T
cells in the injury of demyelinated axons, we established an
adoptive transfer strategy that allowed us to introduce perforin-
competent SCILs into demyelinated but functionally preserved
perforin-deficient mice (Figure 4A). Our goal was to transiently
reconstitute perforin-deficient hosts with perforin-competent
leukocytes that had homed to the spinal cord of demyelinated
donor mice experiencing active axon injury. For these exper-
iments, perforin-deficient hosts at 90 dpi received either a sham
adoptive transfer (RPMI used to resuspend SCILs = ‘‘No AT’’),
perforin-competent SCILs collected from the spinal cord of donor
perforin wildtype B10Q mice at 90 dpi (donor cohorts were
infected at the same time as host cohorts and were assessed for
motor function in parallel with the perforin-deficient hosts), or
perforin-deficient SCILs collected from perforin knock-out hosts at
90 dpi. Donor SCILs were counted, phenotyped by flow
cytometry, and injected into the tail vein of host perforin-deficient
mice (10
5 SCILs per host for most experiments). As previously
published [23], for every 10
5 cells adoptively transferred,
approximately 10% were CD45
hi and 5% were CD45
hiCD8
+.
At 7 days post-transfer (dpt), we found that hosts that received
perforin-competent SCILs showed a 50% reduction in aggregate
stride length as compared to demyelinated perforin-deficient hosts
that received sham adoptive transfer (P,0.001) (Figure 4B). In
contrast, perforin-deficient hosts that received perforin-deficient
SCILs were unimpaired (P=0.658 vs sham AT; P,0.001 vs
perforin-competent AT) (Figure 4B). Moreover, using the hanging
wire test we observed that adoptive transfer of perforin-competent
SCILs into demyelinated perforin-deficient hosts ablated motor
function by 24 hr post-transfer (Figure 4C). This loss of function
persisted through 14 days (Figure 4C) and has never been seen to
recover within the 2 months that we have followed mice after
adoptive transfer. Loss of function following adoptive transfer of
perforin-competent SCILs was also apparent by runway video
analysis (Movie S3). Adoptive transfer of perforin-deficient SCILs
did not cause loss of function in hosts at any time point. We
conclude from these observations that demyelinated perforin-
deficient hosts are susceptible to rapid and permanent loss of
motor function following adoptive transfer of perforin-competent
SCILs but not following transfer of perforin-deficient SCILs. This
strongly suggests that other axopathic and cytotoxic effector
mechanisms present in the leukocytes collected from 90 dpi
perforin-deficient donors are unable to damage demyelinated
axons and abrogate motor function in our model.
Adoptive transfer of perforin-competent SCILs into perforin-
deficient hosts at 90 dpi did not alter viral load or demyelination.
Perforin-deficient hosts at 7 days after sham adoptive transfer had
5.6160.20 log10 viral copies, compared to 5.4860.34 log10 viral
copies following adoptive transfer of perforin-competent SCILs
(P=0.552 by t-test). Perforin-deficient hosts at 7 days after
adoptive transfer of perforin-deficient SCILs exhibited
29%64.4% spinal demyelination, compared to 27%66.1% spinal
demyelination following adoptive transfer of perforin-competent
SCILs (P=0.349 by t-test).
The adoptive transfer effect depended upon spinal cord
demyelination, as transfer of perforin-competent SCILs into
uninfected B10Q hosts did not alter aggregate stride length or
hanging wire performance. Uninfected hosts receiving sham
adoptive transfer had an aggregate stride of 8161.9 mm and a
time-to-fall of 11863 sec, compared to a stride length of
8363.4 mm and a time-to-fall of 12060 sec in uninfected hosts
receiving perforin-competent SCILs (footprint: P=0.303 by t-test;
hanging wire: P=0.548 by Mann-Whitney rank sum test).
Likewise, the adoptive transfer-induced loss of motor function
only occurred when SCILs were used as effectors. Adoptive
transfer of 10
5 splenocytes from 90 dpi perforin-competent B10Q
donors or 10
5 lymphokine-activated perforin-competent killer cells
(IL-2 stimulated in vitro) failed to affect motor function in
demyelinated perforin-deficient hosts (P=0.675 by one-way
ANOVA for splenocyte or LAK transfer vs control). Likewise, in
agreement with our previous observations regarding the lack of
anti-viral responses in the SCILs at 90 dpi [23], adoptive transfer
of up to 10
6 splenocytes isolated from perforin-competent B10Q
donors subcutaneously immunized with killed TMEV failed to
alter motor function in demyelinated perforin-deficient hosts
(P=0.869 by t-test for splenocytes vs control).
Using evoked motor potentials to assess spinal axon function, we
found that adoptive transfer of perforin-competent SCILs into
demyelinated perforin-deficient hosts resulted in striking disrup-
tion of spinal conduction from the high cervical cord (stimulation
site) to the gastrocnemius muscle (recording site) (Figure 4D).
Compared to perforin-deficient hosts at 90 dpi that received no
adoptive transfer, hosts that received perforin-competent SCILs
showed a 3-fold reduction in motor evoked potential (MEP)
amplitude at 7 days post-transfer (no adoptive transfer vs SCILs
transfer, P,0.001 by t-test) (Figure 4D, 4F). Longitudinal analysis
of MEP failure rate (defined as the number of motor cortical
stimulations that failed to elicit gastrocnemius muscle responses
per the total number of stimulations) in the same perforin-deficient
mice before adoptive transfer (26%616% failure) as compared to
the failure rate after transfer of perforin-competent SCILs
(75%616% failure) revealed that far fewer potentials were
transmitted along the spinal cord (P,0.001 by paired t-test). Of
those potentials that were stimulated, the transmission latency was
increased from 5.460.3 msec (no adoptive transfer) to
Figure 2. MHC class I is expressed in demyelinated lesions. MHC class I expression is localized to sites of demyelination, axon injury, and CD8
+
T cell infiltration. (A–C, I–K, Q) Histology of spinal cord at 90 dpi revealed cellular infiltrate by H&E (A, I, Q), loss of Luxol fast blue stained myelin (B, J),
and dysmorphic Bielschowsky-stained axons (C, K). (D–H, L–P, R–T) Immunostaining further revealed MHC class I expression on fibers in the
demyelinated lesion (D, L, R), MHC class II staining on cells in the demyelinated lesion (E, M), and the presence of CD8
+ (F, N, T), CD4
+ (G, O), and
CD11b
+ (H, P) immune cells within the demyelinated lesion. (S) The axon injury marker APP was also observed on structures within demyelinated
lesions containing MHC class and CD8
+ cells. Scale bar in (A) is 500 mm and refers to (A–H). Scale bar in (I) is 250 mm and refers to (I–P). Scale bar in (Q)
is 50 mm and refers to (Q–T).
doi:10.1371/journal.pone.0012478.g002
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The transmission defect was restricted to the spinal cord, as
peripheral compound motor action potentials (CMAP) from the
sciatic notch to the gastrocnemius muscle did not differ with
regard to latency (P=0.260) (Figure 4G) or amplitude (P=0.477)
(Figure 4H) between controls and mice receiving perforin-
competent SCILs.
Consistent with the observed defect in spinal axon conduction,
we found that adoptive transfer of perforin-competent SCILs into
perforin-deficient demyelinated hosts at 90 dpi led to a
22%68.1% reduction in small-caliber spinal axons (P,0.001 vs
no transfer) (Figure 4I), a 51%613% reduction in medium-caliber
axons (P,0.001 vs no transfer) (Figure 4J), and a 67%615%
reduction in large-caliber axons (P,0.001 vs no transfer)
(Figure 4K). In contrast, adoptive transfer of perforin-deficient
SCILs into perforin-deficient hosts at 90 dpi had no significant
impact on either medium-caliber (P=0.847 vs no transfer) or
large-caliber axons (P=0.859 vs no transfer). Despite the complete
preservation of medium and large axons, there was a 14%
reduction in small-caliber spinal axons following transfer of
perforin-deficient SCILs (P=0.008 vs no transfer). These
observations suggest that medium- and large-caliber demyelinated
axons are directly injured in a perforin-dependent manner by
SCILs, whereas small-caliber axons may be injured by a perforin-
independent mechanism.
Adoptively transferred SCILs home to the spinal cord but
not to the cervical lymph nodes or the brain
To identify the primary locus of effect for the adoptively
transferred SCILs we labeled the cells with CFSE prior to transfer
and then recovered SCILs, brain-infiltrating lymphocytes, cervical
lymph node cells, and peripheral blood mononuclear cells
(PBMCs) at 1 hr post-transfer. Flow cytometry of the isolated cell
preparations revealed that relative to sham transfer animals,
adoptive transfer hosts had small populations of CFSE-labeled
cells in the blood (Figure 5B, 5G, 5H) and in the SCILs (Figure 5C,
5E, 5F) but not in the cervical lymph nodes (Figure 5A) or the
brain (Figure 5D). While further experiments are required to
define the kinetics of infiltration into the CNS, we conclude that
adoptively transferred SCILs are competent to enter the
demyelinated spinal cord.
CD8
+ T cells are necessary and sufficient to injure
demyelinated axons
We next applied our adoptive transfer model to the
identification of the primary effector leukocyte in the SCILs
preparation. To do so, we prepared column-depleted perforin-
competent SCILs preparations deficient in CD8
+ cells, CD4
+
cells, or NK1.1
+ cells. In order to control for possible differences
in total cell load, all depleted and non-depleted populations were
adoptively transferred at 10
5 cells per host. As before, we found
that adoptive transfer of the total perforin-competent SCILs
(Figure 6B) into demyelinated perforin-deficient hosts at 90 dpi
resulted in a rapid and persistent loss of motor function
Figure 3. MHC class I is expressed on axons in demyelinated
lesions. MHC class I expression colocalizes with dysmorphic axons
immunostained for neurofilament. (A, C) MHC class I expression was
observed in the 90 dpi spinal cord on fiber-like structures (red channel
in C). (B, C) These same structures expressed neurofilaments and
exhibited a dysmorphic pattern consistent with injured axons (green
channel in C). Arrowheads point to the same structures in (A) and (B).
doi:10.1371/journal.pone.0012478.g003
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competent SCILs depleted of CD8
+ cells (Figure 6C) did not
induce loss of function in demyelinated perforin-deficient hosts
(P=0.933 vs no transfer) (Figure 6A) (Movie S4). In contrast,
CD4-depleted (P,0.001 vs no transfer) (Figure 6A, 6D) and
NK1.1-depleted (P,0.001 vs no transfer) (not shown) SCILs
triggered the same loss of motor function observed in the total
SCILs adoptive transfer.
To confirm the specific role of CD8
+ T cells in the loss of motor
function, we prepared total perforin-competent SCILs depleted of
CD8
+ cells and then added back 0, 100, 1000, or 10000 column-
purified (negative selection) perforin-competent CD8
+ cells.
Following adoptive transfer of these specific numbers of CD8
+
cells within the context of 10
5 other cell types in the SCILs, we
found that even 1000 CD8
+ cells were sufficient to permanently
disrupt motor function in demyelinated perforin-deficient hosts
(P,0.001 vs CD8-depleted SCILs) (Figure 6E). Moreover,
adoptive transfer of 10000 column-purified (negative selection)
perforin-competent CD8
+ cells in the absence of any other cell
type resulted in robust loss of motor function in demyelinated
perforin-deficient hosts (P,0.001 vs 10
5 CD8-depleted SCILs)
(Figure 6F). Finally, this CD8
+ T cell-mediated, perforin-
dependent loss of motor function did not occur following adoptive
transfer of SCILs into demyelinated b2microglobulin-deficient
B10Q host mice (P,0.001 b2m2/2 hosts vs perforin-deficient
hosts) (Figure 6G). We conclude that the CD8
+ T cell effect
required the presence of surface MHC class I molecules within the
nervous system.
SCILs injure axons of cultured cortical neurons in a
perforin-dependent manner
Evidence from our adoptive transfer model strongly suggested
that CD8
+ T cells in the SCILs are directly axopathic. In order to
further test this hypothesis we asked whether SCILs can injure
the axons of primary cortical neurons in culture. We have
previously proposed that demyelination is a form of axonal stress
associated with trophic factor withdrawal [5]. Based on this, we
cultured H-2
q cortical neurons for one week in the presence of a
growth factor cocktail containing BDNF and IGF-1. Withdrawal
of BDNF from this cocktail for 24 hr triggered a stress response in
the neurons that was marked by a variety of transcriptional
responses, including upregulation of MHC class I (data not
shown). Importantly, withdrawal alone was insufficient to cause
apparent neurite injury (Figure 7A, 7B). Likewise, addition of
SCILs collected from 90 dpi B10.Q mice to cortical neurons that
did not experience trophic withdrawal stress did not induce any
neurite damage after 120 min of co-incubation, despite the fact
that the SCILs appeared to interact with the neurites (Figure 7C,
7D). In contrast, addition of SCILs to cortical neurons
experiencing trophic factor withdrawal stress triggered wide-
spread neurite injury after 120 min co-incubation (Figure 7G,
7H). This injury was marked by neurite beading and disintegra-
tion. Of note, the evolution of this neurite injury required
prolonged interaction, as 15 min co-incubation of SCILs and
stressed neurons was insufficient to trigger observable neurite
injury (Figure 7E, 7F).
Since lymphocytes and other cells present in the SCILs
display a wide range of effector mechanisms we directly tested
the role of perforin in the injury of axons in our in vitro system.
As with our in vivo observations, we found that only perforin-
competent SCILs were able to elicit axon injury as marked by
beading and disintegration of neurofilaments (Figure 8B). The
axons of cells incubated with perforin-deficient SCILs
(Figure 8C) were indistinguishable from untreated axons
(Figure 8A). We conclude that stressed axons are a direct target
of perforin-mediated injury provoked by SCILs. Critically,
because the cultured cortical neurons were not infected with
TMEV, we conclude that the axopathic CD8
+ T cells in the
SCILs population are recognizing a neuron-derived epitope
rather than a viral epitope on MHC class I. Further work is
required to identify the relevant epitopes and the detailed
mechanisms of perforin-mediated axon injury.
Therapeutic immunodepletion of CD8
+ T cells protects
function in demyelinated mice
The robust role of CD8
+ T cells in our SCILs adoptive transfer
model suggested that therapeutic abrogation of these effectors in
wild type B10Q mice during the course of axon injury would
preserve motor function. We have previously observed a
temporal disconnection between demyelination (21–45 dpi) and
axon injury (.45 dpi) in chronically infected B10Q mice [19].
Therefore, we initiated immunodepletion of CD8
+ T cells via
weekly intraperitoneal injections of 0.5 mg of the 2.43 anti-CD8
clone from 45 dpi to 90 dpi. Depletion efficiency was assessed at
52, 75, and 90 dpi by flow cytometry of tail vein blood
(Figure 9B–E) and compared to B10Q mice treated with a
control Ig (OKM1). Motor function, as measured by hanging
wire, did not differ between control and anti-CD8-treated mice at
60 dpi, but function was clearly protected in the CD8
immunodepleted mice at 90 dpi (P,0.001 control vs anti-CD8
at 90 dpi; P=0.571 45 dpi anti-CD8 vs 90 dpi anti-CD8;
P=0.002 45 dpi control vs 90 dpi control) (Figure 9A). Despite
Figure 4. Function and axons are lost following adoptive transfer of perforin-competent cells. Adoptive transfer of perforin-competent
spinal cord infiltrating leukocytes (SCILs) into demyelinated but functionally preserved perforin-deficient hosts induces rapid and permanent (.1 mo)
loss of motor function and spinal axons. All data are presented as mean 695% C.I. Statistical significance defined as *P,0.05, **P,0.01, ***P,0.001.
Significance determined by one-way ANOVA with SNK pairwise posthoc analysis, except electrophysiology, which was analyzed by t-test, and the
hanging wire test, which was analyzed by two-way ANOVA. All measurements made at 7 days post-transfer (dpt) unless otherwise indicated. No AT =
no adoptive transfer controls; +/+ = adoptive transfer of perforin-competent SCILs; 2/2 = adoptive transfer of perforin-deficient SCILs. (A)
Schematic representation of the adoptive transfer paradigm. (B) Adoptive transfer of perforin-competent SCILs into perforin-deficient hosts at 90 dpi
results in significant loss of function as assessed by footprint analysis. In contrast, adoptive transfer of perforin-deficient SCILs into perforin-deficient
hosts causes no loss of function. (C) Longitudinal analysis of motor function by the hanging wire test shows that adoptive transfer of perforin-
competent SCILs into 90 dpi perforin-deficient hosts results in a very rapid loss of function that does not recover over the analyzed time frame. Each
symbol represents an individual animal. (D) Representative motor evoked potentials (MEP) in perforin-deficient 90 dpi hosts receiving either no
adoptive transfer or perforin-competent SCILs adoptive transfer. (E-H) Central motor conduction latency (E) and amplitude (F) were significantly
altered by adoptive transfer of perforin-competent SCILs as compared to perforin-deficient mice at 90 dpi that received no adoptive transfer. In
contrast, peripheral compound motor action potential (CMAP) latency (G) and amplitude (H) were unaffected by adoptive transfer. (I-K) Adoptive
transfer of perforin-competent SCILs into 90 dpi perforin-deficient hosts resulted in significant loss of small- (I), medium- (J), and large- (K) caliber
spinal axons as compared to perforin-deficient 90 dpi hosts that received no adoptive transfer. Transfer of perforin-deficient SCILs into perforin-
deficient hosts caused no loss of medium- (J) or large- (K) caliber axons, but did induce a signficant reduction in small- (I) caliber axons.
doi:10.1371/journal.pone.0012478.g004
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PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12478Figure 5. Adoptively transferred SCILs enter the spinal cord. CFSE-labeled SCILs are recovered from the blood (PBMCs) and spinal cord (SCILs)
60 min after adoptive transfer via tail vein injection. (A) Cervical lymph nodes (CLNs) did not contain green CFSE-labeled cells. (B) Green cells were
recovered in the blood. (C) Green cells were also recovered from the spinal cord after adoptive transfer. (D) No labeled cells were found in the brain
after transfer. (A–D) Red histograms represent the number of cell events observed in hosts that received adoptive transfer of CFSE-labeled SCILs while
blue histograms represent control populations collected from mice that did not receive adoptive transfer. (E–H) Representative flow plots showing
green cells isolated from the spinal cord (F) and blood (H) of hosts receiving CFSE-labeled SCILs, as compared to control spinal cord (E) and blood (G).
doi:10.1371/journal.pone.0012478.g005
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PLoS ONE | www.plosone.org 10 August 2010 | Volume 5 | Issue 8 | e12478the difference in function between the groups, viral load did not
differ between control (5.761.2 log10 viral copies) and anti-CD8-
treated mice (5.760.6 log10 viral copies) at 90 dpi (P=0.948).
Likewise, demyelinated lesion load did not differ between control
(34%614%) and anti-CD8-treated mice (35%610%) (P=0.880).
We conclude that immunodepletion of CD8
+ T cells may be a
valuable tool for preventing axon injury in the demyelinated
central nervous system.
Discussion
Keeping in mind the pathogenic, mechanistic, and patholog-
ical heterogeneity of MS, our findings suggest that CD8
+ T cells,
working via a perforin-dependent mechanism, are the primary
effector population responsible for injury and loss of demyeli-
nated axons. Although perforin-dependent CD8
+ T cells are both
necessary and sufficient to injure demyelinated axons and destroy
motor function, this effector mechanism is irrelevant to
demyelination in H-2
q MHC haplotype mice chronically infected
with TMEV. Indeed, in the absence of perforin, the preservation
of motor function to uninfected levels despite the presence of
considerable spinal cord demyelination is reminiscent of a
radiologically isolated demyelinating syndrome [25]. While our
adoptive transfer experiments do not address the relevance of
non-perforin CD8
+ T cell effector mechanisms to demyelination,
our observation that therapeutic depletion of CD8
+ T cells during
the chronic phase of disease protects motor function without
altering demyelination argues that these cells are predominantly
involved in direct injury of axons. Our findings also lend strong
support to the idea that demyelination is necessary, but not
sufficient, to damage axons and chronically disrupt motor
function.
Although we have only just begun to explore the role of MHC
class I in the injury of axons in our model, several observations
s u g g e s tt h a tc l a s sIe x p r e s s i o ni sn e c e s s a r yf o rC D 8
+ Tc e l l -
mediated damage. First, adoptive transfer of perforin-competent
CD8
+ T cells collected from chronically demyelinated wildtype
H-2
q mice into demyelinated but functionally preserved b2-
microglobulin deficient H-2
q mice did not result in loss of motor
function (Figure 6G). This suggests that surface expression of
MHC class I in the donor mice is required for CD8
+ Tc e l l
recognition of demyelinated axons. Second, we have found that
adoptive transfer of perforin-competent CD8
+ T cells collected
from chronically demyelinated wild type H-2
q mice into
demyelinated but functionally preserved perforin-deficient H-2
b
mice [26] also does not result in loss of function, suggesting that
MHC mismatch prevents CD8
+ T cell recognition of the
demyelinated axons (data not shown). Third, in preliminary
experiments we have found that CD8
+ SCILs recognize and
injure axons of cultured H-2
q cortical neurons (Figures 7 and 8)
but do not recognize or injure cultured H-2
b cortical neurons
(data not shown). Fourth, we have observed MHC class I
immunostaining on longitudinally transverse fiber-like structures
in demyelinated lesions and these structures exhibit markers
of axon injury and are in proximity to CD8
+ T cells (Figures 2
and 3).
Despite the apparent MHC class I dependence of CD8+ T cell-
mediated axon injury, our observations suggest that these T cells
are not antiviral. While we have started exploring possible
autoantigens presented by MHC class I on demyelinated axons,
our current findings only suggest that viral epitopes are not
relevant. We have recently published an extensive characterization
of CD8
+ T cells present in the spinal cord at 90 dpi and concluded
that these cells, although evidently activated acute effectors, were
not competent to kill virus-infected targets in vitro [23]. Likewise,
in our current experiments, adoptive transfer of large numbers of
perforin-competent antiviral splenocytes into demyelinated but
functionally preserved perforin-deficient hosts failed to impact
motor function, suggesting that antiviral reactivity is not sufficient
to explain axon injury. In addition, perforin-competent SCILs
robustly damaged the neurites of cultured cortical neurons that
were never infected (Figures 7 and 8), suggesting that antiviral
reactivity is not necessary for axon injury. Especially with regard to
CD8
+ T cell-mediated injury of demyelinated corticospinal motor
axons, this virus independence is consistent with the absence of
chronic infection in the brain at 90 dpi [19]. In ongoing
experiments using non-viral models of demyelination we intend
to directly determine whether CD8
+ T cells isolated from the
demyelinated spinal cord at 90 dpi are competent to damage
demyelinated axons in uninfected hosts.
We recognize that CD8
+ T cells may play a role via other
effector mechanisms in myelin damage [27], immune regulation
[28], or even in myelin repair [29]. We also acknowledge that
the role of CD8
+ T cells in axon injury may be complicated or
reversed in some animal models of demyelinating disease [30].
However, our current findings provoke a cautious optimism that
manipulation of CD8
+ T cells may be therapeutically relevant to
human MS. While the field has largely concentrated on
therapeutic intervention in the function of CD4
+ Tc e l l si n
CNS, we suggest that explicitly targeting CD8
+ T cells may be a
viable option for preserving axons. A CD8
+ T cell depleting or
blocking therapy may permit considerable stabilization of disease
progression, essentially preventing the conversion of relapsing-
remitting patients to a secondary progrssive phase. At the same
time, a CD8-centric therapy may sidestep the complications of
immunocompromise associated with therapeutic blockade of
CNS infiltration by all lymphocytes [31].
Materials and Methods
Detailed methods are provided in File S1.
Figure 6. CD8
+ T cells are necessary and sufficient for loss of function and axon injury following adoptive transfer. CD8
+ spinal cord
infiltrating T cells are necessary and sufficient to injure demyelinated axons in a perforin- and MHC class I-dependent manner. All data are presented
as mean 695% C.I. Statistical significance defined as *P,0.05, **P,0.01, ***P,0.001. Significance determined by two-way ANOVA with SNK pairwise
posthoc analysis. All SCILs derived from 90 dpi perforin-competent donors. No CD8 = CD8-depleted SCILs; CD8-only = immuno-isolated perforin-
competent CD8
+ SCILs; b2m2/2 = b2 microglobulin-deficient B10Q host; CON = control IgG-treated; aCD8 = anti-CD8 IgG-treated; PBMC =
peripheral blood mononuclear cells. (A) Adoptive transfer of CD8-depleted SCILs did not induce loss of motor function, as compared to adoptive
transfer of total SCILs or CD4-depleted SCILs. (B–D) Representative flow plots of total SCILs (B), CD8-depleted SCILs (C), and CD4-depleted SCILs (D)
used for adoptive transfer. (E) Immuno-isolated CD8
+ SCILS were added back to CD8-depleted total SCILs to determine how many were necessary to
induce loss of motor function. Even 1,000 CD8
+ SCILs were competent to significantly impair function. (F) Adoptive transfer of 10,000 immuno-
isolated CD8
+ SCILs, in the absence of any other cell type, induced a significant loss of function as compared to adoptive transfer of CD8-depleted
SCILs. (G) Adoptive transfer of total perforin-competent SCILs into perforin-deficient hosts versus b2 microglobulin-deficient hosts revealed that
surface expression of MHC class I is necessary for loss of motor function.
doi:10.1371/journal.pone.0012478.g006
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Animal use and care were in accordance with National
Institutes of Health guidelines. All procedures were approved by
the Mayo Clinic Institutional Animal Care and Use Committee
(NIH OLAW assurance number A3291-01).
Mice
Perforin-deficient mice on an H-2
q background were previ-
ously described [19]. Homozygous beta-2 microglobulin (b2m)-
d e f i c i e n tm i c eo na nH - 2
b background were obtained from the
Whitehead Institute and were subsequently bred on an H-2
q
background in our facility. Gender was mixed for all experimen-
tal groups.
Virus
The Daniel’s strain of TMEV was used for all experiments. At
4–6 weeks of age, mice were inoculated intracerebrally with
2610
5 PFU of TMEV in a total volume of 10 mL.
Preparation of cells and adoptive transfer
Spinal cord infiltrating leukocytes (SCILs), peripheral blood
mononuclear cells, and splenocytes were prepared as previously
described [23]. SCILs or other cell populations were resuspended
in RPMI to a final concentration of 10
6 cells per mL. Each mouse
received 100 mL of cell suspension via tail vein injection.
Histopathology of spinal cord tissue and axon analysis
Demyelination was measured by camera lucida drawing of 4%
para-phenylenediamine-stained sections as previously described
[19,21,24]. Axons at the T6 thoracic level were automatically
analyzed at 60X magnification from each animal according to a
sampling scheme previously developed [21]. Images were captured
from regions containing no demyelination to ensure the measure-
ment of only myelinated fibers. Each field measured 17,675 mm
2.
A total of 2.16 mm
2 from sham-infected controls, 1.76 mm
2 from
perforin-competent mice, and 1.34 mm
2 from perforin-deficient
mice were collected at 90 dpi. A total of 0.74 mm
2 from perforin-
deficient hosts receiving sham adoptive transfer, 0.53 mm
2 from
perforin-deficient hosts receiving adoptive transfer of SCILs from
perforin-competent donors, and 0.73 mm
2 from perforin-deficient
hosts receiving adoptive transfer of SCILs from perforin-deficient
donors were collected.
Behavioral analyses and electrophysiology
Behavioral measurements and electrophysiology methodology
are described in detail in the supplemental methods.
In vivo immunodepletion of CD8
+ T cells.
Wildtype B10Q mice were immunodepleted of CD8
+ T cells via
weekly intraperitoneal injections of 0.5 mg of the anti-CD8 2.43
clone (ATCC, No. TIB 210) from 45 dpi to 90 dpi. Control
animals were treated in parallel with 0.5 mg of the control
antibody OKM1 (ATCC, No. CRL 8026). Antibodies were
prepared by ammonium sulfate precipitation from 2.43 and
OKM1 hybridoma supernatants.
Statistics
All data are presented as mean695% confidence interval (CI).
Statistical tests for every analysis are described in detail in Table
S1. Normality was used when appropriate to determine whether
parametric or non-parametric tests were employed. All calcula-
tions were performed using SigmaPlot 11 (Systat Software,
Chicago, IL). Every experiment was repeated a minimum of 3
times on separate animal cohorts.
Figure 7. SCILs directly injure stressed neurites in vitro in the absence of viral infection. The neurites of cortical neurons non-lethally
stressed by withdrawal of trophic factor support are targets of SCILs-mediated injury despite the complete absence of viral infection. (A, B)
Trophic withdrawal alone is insufficient to injure cortical neuron neurites. (C, D) Addition of SCILs collected from 90 dpi B10.Q mice to non-
stressed cortical neuron cultures for 120 min did not induce neurite injury. (E, F) Addition of SCILs to stressed cortical neurons for 15 min also
did not result in any discernable neurite injury. (G, H) However, by 120 min of SCILs co-incubation with stressed cortical neurons, widespread
neurite beading and disintegration was observed. Scale bar in (A) is 100 mm and refers to (A, C, E, G). Scale bar in (B) is 25 mm and refers to (B, D,
F, H).
doi:10.1371/journal.pone.0012478.g007
Figure 8. SCILs directly injure stressed axons in vitro in a
perforin-dependent manner. Perforin-competent but not perforin-
deficient SCILs induce beading and fragmentation of neurofilaments in
cortical neuron axons in vitro in the absence of viral infection. (A)
Neurofilament staining in cortical neuron axons not exposed to SCILs.
(B) Beading and disintegration of neurofilaments elicited by perforin-
competent SCILs incubated with cortical neurons for 120 min. (C)
Perforin-deficient SCILs did not trigger axon injury. Scale bar in (C) is
50 mm and refers to (A–C).
doi:10.1371/journal.pone.0012478.g008
CD8
+ T Cells Injure Axons
PLoS ONE | www.plosone.org 13 August 2010 | Volume 5 | Issue 8 | e12478Supporting Information
Figure S1 Absolute numbers of CD45
hiCD8
+ T cells and
CD45
hiCD4
+ T cells do not differ in SCILs prepared from
perforin competent and perforin deficient hosts at 90 dpi. No
differences in the percentages of CD8
+ cells and CD4
+ cells
(expressed as a percentage of CD45
hi T cells) are seen in SCILs
prepared from perforin competent versus perforin deficient hosts
at 90 dpi. All data are expressed as mean 695% C.I. Significance
was analyzed by t-test.
Found at: doi:10.1371/journal.pone.0012478.s001 (0.10 MB TIF)
Figure S2 Motor function as assessed by direct observation of
posture is impaired in perforin competent hosts (a), but is
preserved in perforin deficient hosts (b).
Found at: doi:10.1371/journal.pone.0012478.s002 (1.75 MB
TIF)
File S1 Additional materials and methods.
Found at: doi:10.1371/journal.pone.0012478.s003 (0.06 MB
DOC)
Movie S1 Open field video analysis demonstrates preservation
of motor function in perforin deficient mice and impairment of
motor function in perforin competent mice at 90 dpi.
Found at: doi:10.1371/journal.pone.0012478.s004 (5.60 MB
MOV)
Movie S2 Runway video analysis demonstrates preservation of
motor function in perforin deficient mice and impairment of
motor function in perforin competent mice at 90 dpi.
Found at: doi:10.1371/journal.pone.0012478.s005 (3.53 MB
MOV)
Movie S3 Runway video analysis demonstrates loss of motor
function in perforin deficient hosts after adoptive transfer of SCILs
from perforin competent donors.
Found at: doi:10.1371/journal.pone.0012478.s006 (3.81 MB
MOV)
Movie S4 Open field video analysis demonstrates motor
impairment in perforin deficient hosts after adoptive transfer of
total SCILs from perforin competent donors, whereas no
impairment occurs in perforin deficient hosts after adoptive
transfer of CD8
+ depleted SCILs from perforin competent donors.
Found at: doi:10.1371/journal.pone.0012478.s007 (5.20 MB
MOV)
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